A Clinical Trial of Lurasidone in Treatment of Schizophrenia

NCT02002832 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

388

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Lurasidone tablets
DRUG: Risperidone tablets

Sponsor

Sumitomo Pharma (Suzhou) Co., Ltd.